RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia

BACKGROUND: Variation in terms of outcome and toxic side effects of treatment exists among acute myeloid leukemia (AML) patients on chemotherapy with cytarabine (Ara-C) and daunorubicin (Dnr). Candidate Ara-C metabolizing gene expression in primary AML cells is proposed to account for this variation...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pharmacogenomics
Glavni autori: Abraham, Ajay, Varatharajan, Savitha, Karathedath, Sreeja, Philip, Chepsy, Lakshmi, Kavitha M, Jayavelu, Ashok Kumar, Mohanan, Ezhilpavai, Janet, Nancy Beryl, Srivastava, Vivi M, Shaji, Ramachandran V, Zhang, Wei, Abraham, Aby, Viswabandya, Auro, George, Biju, Chandy, Mammen, Srivastava, Alok, Mathews, Vikram, Balasubramanian, Poonkuzhali
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115907/
https://ncbi.nlm.nih.gov/pubmed/26083014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.15.44
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items